324 related articles for article (PubMed ID: 2687626)
21. A comparison of the effect of selenium on the mutagenicity and metabolism of benzo[a]pyrene in rat and hamster liver S9 activation systems.
Teel RW
Cancer Lett; 1984 Oct; 24(3):281-9. PubMed ID: 6388822
[TBL] [Abstract][Full Text] [Related]
22. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
[TBL] [Abstract][Full Text] [Related]
23. Mutagenicity of 7H-dibenzo[c,g]carbazole and metabolites in Salmonella typhimurium.
Schoeny R; Warshawsky D
Mutat Res; 1987 Aug; 188(4):275-86. PubMed ID: 3302697
[TBL] [Abstract][Full Text] [Related]
24. Promutagen activation with mammalian and avian S9 liver microsomes.
Tometsko AM; Sheridan KM; DeTraglia MC
J Appl Toxicol; 1981 Feb; 1(1):11-4. PubMed ID: 6309943
[TBL] [Abstract][Full Text] [Related]
25. Assessing the use of known mutagens to calibrate the Salmonella typhimurium mutagenicity assay: II. With exogenous activation.
Claxton LD; Houk VS; Warner JR; Myers LE; Hughes TJ
Mutat Res; 1991 Oct; 253(2):149-59. PubMed ID: 1922141
[TBL] [Abstract][Full Text] [Related]
26. Activation of phenanthrene to mutagenic metabolites and evidence for at least two different activation pathways.
Oesch F; Bücker M; Glatt HR
Mutat Res; 1981 Mar; 81(1):1-10. PubMed ID: 7019683
[TBL] [Abstract][Full Text] [Related]
27. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene].
Pavlov IuI; Khromov-Borisov NN
Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182
[TBL] [Abstract][Full Text] [Related]
28. Mutagenicity evaluation of HC Blue No. 1 and HC Blue No. 2. III. Effects in the Salmonella typhimurium/Escherichia coli reversion assay and the mouse lymphoma L5178Y TK+/- forward mutation assay.
Oberly TJ; Kokkino AJ; Bewsey BJ; Richardson KK
Mutat Res; 1990 Jun; 241(2):151-9. PubMed ID: 2189067
[TBL] [Abstract][Full Text] [Related]
29. The Salmonella/mammalian microsome mutagenicity test: comparison of human and rat livers as activating systems.
Beaune P; Lemestré-Cornet R; Kremers P; Albert A; Gielen J
Mutat Res; 1985 Jun; 156(3):139-46. PubMed ID: 3889631
[TBL] [Abstract][Full Text] [Related]
30. The activation of mutagens in diesel particle extract with rat liver S9 enzymes.
Pederson TC; Siak JS
J Appl Toxicol; 1981 Apr; 1(2):61-6. PubMed ID: 6206115
[TBL] [Abstract][Full Text] [Related]
31. Assay of phenacetin genotoxicity using in vitro and in vivo test systems.
De Flora S; Russo P; Pala M; Fassina G; Zunino A; Bennicelli C; Zanacchi P; Camoirano A; Parodi S
J Toxicol Environ Health; 1985; 16(3-4):355-77. PubMed ID: 3910846
[TBL] [Abstract][Full Text] [Related]
32. Bioactivation and biotransformation of 1-nitropyrene in liver, lung and nasal tissue of rats.
Bond JA
Mutat Res; 1983 Dec; 124(3-4):315-24. PubMed ID: 6361542
[TBL] [Abstract][Full Text] [Related]
33. Genetic activity of 2-aminofluorene in the salmonella/erythrocyte mutagenicity assay.
Cantelli-Forti G; Paolini M; Hrelia P; Corsi C; Bronzetti G
Mutat Res; 1986 Jul; 174(3):169-73. PubMed ID: 3523233
[TBL] [Abstract][Full Text] [Related]
34. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
Clive D; Turner N; Krehl R
Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
[TBL] [Abstract][Full Text] [Related]
35. Mutagenicity of cyclopenta-fused isomers of benz(a)anthracene in bacterial and rodent cells and identification of the major rat liver microsomal metabolites.
Nesnow S; Leavitt S; Easterling R; Watts R; Toney SH; Claxton L; Sangaiah R; Toney GE; Wiley J; Fraher P
Cancer Res; 1984 Nov; 44(11):4993-5003. PubMed ID: 6386146
[TBL] [Abstract][Full Text] [Related]
36. Is a liver comparable to a liver? A comparison of different rat-derived S9-fractions with a biotechnological animal-free alternative in the Ames fluctuation assay.
Brendt J; Crawford SE; Velki M; Xiao H; Thalmann B; Hollert H; Schiwy A
Sci Total Environ; 2021 Mar; 759():143522. PubMed ID: 33246726
[TBL] [Abstract][Full Text] [Related]
37. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
Prival MJ; Mitchell VD
Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
[TBL] [Abstract][Full Text] [Related]
38. Mutagenicity testing with the Salmonella/hepatocyte and the Salmonella/microsome assays. A comparative study with some known genotoxic compounds.
Bos RP; Neis JM; van Gemert PJ; Henderson PT
Mutat Res; 1983 Nov; 124(2):103-12. PubMed ID: 6358883
[TBL] [Abstract][Full Text] [Related]
39. Comparison of rat and guinea pig as sources of the S9 fraction in the Salmonella/mammalian microsome mutagenicity test.
Baker RS; Bonin AM; Stupans I; Holder GM
Mutat Res; 1980 Jun; 71(1):43-52. PubMed ID: 6993931
[TBL] [Abstract][Full Text] [Related]
40. Complex effects of retinol on the metabolic activation of 2-aminofluorene.
Balbinder E; Stick SM; Sharma OK
Environ Mutagen; 1983; 5(5):665-78. PubMed ID: 6352252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
